SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-24-032843
Filing Date
2024-03-18
Accepted
2024-03-18 16:20:35
Documents
71
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K fbrx-20231231.htm   iXBRL 10-K 2028588
2 EX-10.16 fbrx-ex10_16.htm EX-10.16 425873
3 EX-10.17 fbrx-ex10_17.htm EX-10.17 20027
4 EX-21.1 fbrx-ex21_1.htm EX-21.1 8184
5 EX-23.1 fbrx-ex23_1.htm EX-23.1 4958
6 EX-23.2 fbrx-ex23_2.htm EX-23.2 3992
7 EX-31.1 fbrx-ex31_1.htm EX-31.1 14975
8 EX-31.2 fbrx-ex31_2.htm EX-31.2 15077
9 EX-32.1 fbrx-ex32_1.htm EX-32.1 8643
10 EX-32.2 fbrx-ex32_2.htm EX-32.2 8540
11 EX-97.1 fbrx-ex97_1.htm EX-97.1 50026
  Complete submission text file 0000950170-24-032843.txt   8246643

Data Files

Seq Description Document Type Size
12 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT fbrx-20231231.xsd EX-101.SCH 1059387
75 EXTRACTED XBRL INSTANCE DOCUMENT fbrx-20231231_htm.xml XML 1195780
Mailing Address 3060 PEGASUS PARK DRIVE BUILDING 6 DALLAS TX 75247
Business Address 3060 PEGASUS PARK DRIVE BUILDING 6 DALLAS TX 75247 (310) 618-6994
Forte Biosciences, Inc. (Filer) CIK: 0001419041 (see all company filings)

IRS No.: 261243872 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38052 | Film No.: 24759311
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)